SCHEMBL5899474

SCHEMBL5899474

CCCc1ccc(S(=O)(=O)N(CC)C(C)C(=O)c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.50
ADRA2A P08913 1/20 0.50
ADRA2B P18089 1/20 0.50
HTR2A P28223 1/20 0.50
HRH1 P35367 1/20 0.50
KCNH2 Q12809 1/20 0.50
CNR2 P34972 2/20 0.47
KEAP1 Q14145 3/20 0.42
NFE2L2 Q16236 2/20 0.42
HTT P42858 1/20 0.42
TAS2R14 Q9NYV8 2/20 0.42
OPRK1 P41145 1/20 0.41
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
MMP13 P45452 1/20 0.40
PSEN1 P49768 1/20 0.40
PSEN2 P49810 1/20 0.40
APH1B Q8WW43 1/20 0.40
NCSTN Q92542 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899478 0.88 PGR (0.59) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL5899623 0.86 PGR (0.54) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL5899600 0.86 PGR (0.54) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL5899470 0.85 PGR (0.52) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL5899459 0.85 PGR (0.52) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL5899444 0.82 PGR (0.50) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL5899428 0.80 PGR (0.50) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL5899424 0.80 PGR (0.52) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL5899453 0.79 PGR (0.51) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL5899553 0.76 PGR (0.58) PGRADRA2AADRA2BHTR2AHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 PGR 822/4885ADRA2A 1796/4885ADRA2B 1026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.